Clinical trials
Withdrawn Breast Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 10 |
| 2013 | 4 |
| 2014 | 11 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 125 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 5 |
| City of Hope Medical Center | 4 |
| M.D. Anderson Cancer Center | 4 |
| Stanford University | 4 |
| University of Chicago | 4 |
| University of Southern California | 4 |
| Milton S. Hershey Medical Center | 3 |
| Duke University | 2 |
| Fudan University | 2 |
| Institut Bergonié | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 125 |
| Neoplasms | 7 |
| Carcinoma, Intraductal, Noninfiltrating | 5 |
| Colonic Neoplasms | 5 |
| Fatigue | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Lymphedema | 4 |
| Carcinoma, Ductal, Breast | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.